Enfermedad de Ménière

REFERENCIAS

1 Bronstein A, Lempert T. Dizziness. A practical approach to diagnosis and management. Cambridge University Press, 2007.
2 Fiorino F, Pizzini FB. MRI performed after intratympanic gadolinium administration in patients with Meniere’s disease. Correlation with symptoms and signs. Eur Arch Otolaryngol 2011; 268:181-7.
3 Harris JP, Alexander TH. Current-day prevalence of Meniere’s syndrome. Audiol Neurootol 2010; 15:318-22.
4 McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice—fourth national study. 1991-1992. Office of Population Censuses and Surveys, 1995.
5 Thomas K, Harrison MS. Long-term follow-up of 610 cases of Meniere’s Disease. Proc R Soc Med 1971; 64:853-7.
6 Kentala E. Characteristics of six otological diseases involving vertigo. Am J Otol 1996; 17:883-892.
7 Silverstein H, Smouha E, Jones R. Natural history vs surgery for Ménière’s disease. Otolaryngol Head Neck Surg 1989; 100:6-16.
8 Odkvist LM, Bergenius J. Drop attacks in Meniere’s disease. Acta Otolaryngol 1988; 455:82-5.
9 Drachman DA, Hart CW. An approach to the dizzy patient. Neurology 1972; 22:223-34.
10 Evans J. Transient neurological dysfunction and risk of stroke in an elderly English population: the different significance of vertigo and non-rotatory dizziness. Age Ageing 1990; 19:43-9.
11 Barraclough K, Bronstein A. Diagnosis in general practice: vertigo. BMJ 2009; 339:749-52
12 Van Cruijsen N, Jaspers JP, van de Wiel HB, Wit HP, Albers FW. Psychological assessment of patients with Menière’s disease. Int J Audiol 2006; 45:496-502.
13 Naftalin L,Harrison MS. Vertigo. J Laryngol Otol 1963; 77:827-34.
14 James A, Burton MJ. Betahistine for Ménière’s disease or syndrome. Cochrane Database Syst Rev 2001;1:CD001873.
15 Burgess A, Kundu S. Diuretics for Ménière’s disease or syndrome. Cochrane Database Syst Rev 2006;3:CD003599.
16 Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005; 133:285-94.
17 Boleas-Aguirre MS, Lin FR, Della Santina CC, Minor LB, Carey JP. Longitudinal studies with intra-tympanic dexamethasone in the treatment of Meniere’s Disease. Otol Neurol 2008; 29:33-8.
18 Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Meniere’s disease: a meta-analysis. Otol Neurotol 2004; 25:544-52.
19 Huon L-K, Fang T-Y. Outcomes of intratympanic gentamicin injection to treat Meniere’s disease. Otol Neurotol 2012; 33:706-14.
20 Thomsen J, Bretlau P. Placebo effect in surgery for Meniere’s disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 1981; 107:271-7.